Alzheimer’s Research UK has funded £437,000 of research into posterior cortical atrophy (PCA) and were one of the first charities to invest consistently in this important area of research.

Alzheimer’s Research UK helped to fund the largest genetic study of PCA to date. The researchers found several genes that may influence a person’s risk of PCA, some of which had previously been linked to Alzheimer’s. You can’t be tested for these risk genes on the NHS because many only have a small effect on risk. However, their discovery is helping researchers understand more about why some people develop PCA.

We have now funded over £64 million of pioneering research to help advance the understanding of all types of dementia, discovering new ways to diagnose, prevent and treat the diseases that cause dementia.

Backed by our passionate scientists and supporters, we are challenging the way people think about dementia, and investing in research to make breakthroughs possible.

What is posterior cortical atrophy?

Find out more about the symptoms and causes of posterior cortical atrophy, and the treatments currently available.


Research projects

Was this information helpful?

Let us know what you think by filling out this short survey.


Dementia Research Infoline

Want to know more about current research? Keen to get involved in research projects?

Contact the Dementia Research Infoline,

9am-5pm, Monday to Friday

0300 111 5 111